Global pharmaceutical firm GSK is creating a new corporate headquarters in downtown London, according to WRAL Techwire.

“Our new headquarters represents an important next step for GSK,” said CEO Emma Walmsley in the announcement.

“As a global biopharma company, we are proud to call London our home and look forward to the opportunities for even closer collaboration with the city’s world-class science, academic and healthcare institutions. Our new headquarters will provide a fantastic new focal point for GSK people to meet, collaborate and ultimately deliver solutions for the urgent healthcare challenges facing the world.”

The building will house some 3,000 workers and is already under construction with move-in expected in 2024.